āĻšā§°āĻ•āĻžā§°
ā§Ģā§Ļ āĻšāĻžāĻœāĻžā§°+
āĻĄāĻžāĻ‰āĻ¨āĻ˛â€™āĻĄ
āĻ¸āĻŽāĻ˛ā§° āĻŽā§‚āĻ˛ā§āĻ¯āĻžāĻ‚āĻ•āĻ¨
PEGI ā§Š
āĻ¸ā§āĻ•ā§ā§°ā§€āĻ¨āĻļā§āĻŦāĻŸā§° āĻĒā§āĻ°āĻ¤āĻŋāĻšā§āĻ›āĻŦāĻŋ
āĻ¸ā§āĻ•ā§ā§°ā§€āĻ¨āĻļā§āĻŦāĻŸā§° āĻĒā§āĻ°āĻ¤āĻŋāĻšā§āĻ›āĻŦāĻŋ
āĻ¸ā§āĻ•ā§ā§°ā§€āĻ¨āĻļā§āĻŦāĻŸā§° āĻĒā§āĻ°āĻ¤āĻŋāĻšā§āĻ›āĻŦāĻŋ
āĻ¸ā§āĻ•ā§ā§°ā§€āĻ¨āĻļā§āĻŦāĻŸā§° āĻĒā§āĻ°āĻ¤āĻŋāĻšā§āĻ›āĻŦāĻŋ
āĻ¸ā§āĻ•ā§ā§°ā§€āĻ¨āĻļā§āĻŦāĻŸā§° āĻĒā§āĻ°āĻ¤āĻŋāĻšā§āĻ›āĻŦāĻŋ
āĻ¸ā§āĻ•ā§ā§°ā§€āĻ¨āĻļā§āĻŦāĻŸā§° āĻĒā§āĻ°āĻ¤āĻŋāĻšā§āĻ›āĻŦāĻŋ
āĻ¸ā§āĻ•ā§ā§°ā§€āĻ¨āĻļā§āĻŦāĻŸā§° āĻĒā§āĻ°āĻ¤āĻŋāĻšā§āĻ›āĻŦāĻŋ
āĻ¸ā§āĻ•ā§ā§°ā§€āĻ¨āĻļā§āĻŦāĻŸā§° āĻĒā§āĻ°āĻ¤āĻŋāĻšā§āĻ›āĻŦāĻŋ
āĻ¸ā§āĻ•ā§ā§°ā§€āĻ¨āĻļā§āĻŦāĻŸā§° āĻĒā§āĻ°āĻ¤āĻŋāĻšā§āĻ›āĻŦāĻŋ
āĻ¸ā§āĻ•ā§ā§°ā§€āĻ¨āĻļā§āĻŦāĻŸā§° āĻĒā§āĻ°āĻ¤āĻŋāĻšā§āĻ›āĻŦāĻŋ
āĻ¸ā§āĻ•ā§ā§°ā§€āĻ¨āĻļā§āĻŦāĻŸā§° āĻĒā§āĻ°āĻ¤āĻŋāĻšā§āĻ›āĻŦāĻŋ
āĻ¸ā§āĻ•ā§ā§°ā§€āĻ¨āĻļā§āĻŦāĻŸā§° āĻĒā§āĻ°āĻ¤āĻŋāĻšā§āĻ›āĻŦāĻŋ
āĻ¸ā§āĻ•ā§ā§°ā§€āĻ¨āĻļā§āĻŦāĻŸā§° āĻĒā§āĻ°āĻ¤āĻŋāĻšā§āĻ›āĻŦāĻŋ
āĻ¸ā§āĻ•ā§ā§°ā§€āĻ¨āĻļā§āĻŦāĻŸā§° āĻĒā§āĻ°āĻ¤āĻŋāĻšā§āĻ›āĻŦāĻŋ
āĻ¸ā§āĻ•ā§ā§°ā§€āĻ¨āĻļā§āĻŦāĻŸā§° āĻĒā§āĻ°āĻ¤āĻŋāĻšā§āĻ›āĻŦāĻŋ

āĻāĻ‡ āĻāĻĒā§â€ŒāĻŸā§‹ā§° āĻŦāĻŋāĻˇā§Ÿā§‡

The U.S. Medical Eligibility Criteria for Contraceptive Use comprises recommendations for the use of specific contraceptive methods by patients who have certain characteristics or medical conditions. The U.S. Selected Practice Recommendations for Contraceptive Use addresses a select group of common, yet sometimes controversial or complex, issues regarding initiation and use of specific contraceptive methods. The app is developed directly from the CDC Morbidity and Mortality Weekly Report (MMWR) by the Division of Reproductive Health and covers more than 60 characteristics or medical conditions (U.S. MEC) and numerous clinical situations (U.S. SPR). These recommendations are intended to assist healthcare providers when they counsel women, men, and couples about contraceptive method choice and use. Although these recommendations are meant to serve as a source or clinical guidance, healthcare providers should always consider the individual clinical circumstances of each person seeking family planning services.
āĻ†āĻĒāĻĄā§‡â€™āĻŸ āĻ•ā§°āĻž āĻ¤āĻžā§°āĻŋāĻ–
ā§§ā§§-ā§Ļā§¯-ā§¨ā§Ļā§¨ā§Ē

āĻĄā§‡āĻŸāĻž āĻ¸ā§ā§°āĻ•ā§āĻˇāĻž

āĻŦāĻŋāĻ•āĻžāĻļāĻ•ā§°ā§āĻ¤āĻžāĻ¸āĻ•āĻ˛ā§‡ āĻ†āĻĒā§‹āĻ¨āĻžā§° āĻĄā§‡āĻŸāĻž āĻ•ā§‡āĻ¨ā§‡āĻ•ā§ˆ āĻ¸āĻ‚āĻ—ā§ā§°āĻš āĻ†ā§°ā§ āĻļā§āĻŦā§‡ā§ŸāĻžā§° āĻ•ā§°ā§‡ āĻ¸ā§‡ā§ŸāĻž āĻŦā§āĻœāĻŋ āĻĒā§‹ā§ąāĻžā§° āĻœā§°āĻŋā§ŸāĻ¤ā§‡ āĻ¸ā§ā§°āĻ•ā§āĻˇāĻž āĻ†ā§°āĻŽā§āĻ­ āĻšā§ŸāĨ¤ āĻĄā§‡āĻŸāĻžā§° āĻ—ā§‹āĻĒāĻ¨ā§€ā§ŸāĻ¤āĻž āĻ†ā§°ā§ āĻ¸ā§ā§°āĻ•ā§āĻˇāĻž āĻĒā§ā§°āĻŖāĻžāĻ˛ā§€ āĻ†āĻĒā§‹āĻ¨āĻžā§° āĻŦā§āĻ¯ā§ąāĻšāĻžā§°, āĻ…āĻžā§āĻšāĻ˛ āĻ†ā§°ā§ āĻŦāĻ¯āĻŧāĻ¸ā§° āĻ“āĻĒā§°āĻ¤ āĻ­āĻŋāĻ¤ā§āĻ¤āĻŋ āĻ•ā§°āĻŋ āĻ­āĻŋāĻ¨ā§āĻ¨ āĻšâ€™āĻŦ āĻĒāĻžā§°ā§‡āĨ¤ āĻŦāĻŋāĻ•āĻžāĻļāĻ•ā§°ā§āĻ¤āĻžāĻ—ā§°āĻžāĻ•ā§€ā§Ÿā§‡ āĻāĻ‡ āĻ¤āĻĨā§āĻ¯āĻ–āĻŋāĻ¨āĻŋ āĻĒā§ā§°āĻĻāĻžāĻ¨ āĻ•ā§°āĻŋāĻ›ā§‡ āĻ†ā§°ā§ āĻ¸āĻŽā§Ÿā§° āĻ˛āĻ—ā§‡ āĻ˛āĻ—ā§‡ āĻā§ŸāĻž āĻ†āĻĒāĻĄā§‡â€™āĻŸ āĻ•ā§°āĻŋāĻŦ āĻĒāĻžā§°ā§‡āĨ¤
āĻ¤ā§ƒāĻ¤ā§€ā§Ÿ āĻĒāĻ•ā§āĻˇā§° āĻ¸ā§ˆāĻ¤ā§‡ āĻ•ā§‹āĻ¨ā§‹ āĻĄā§‡āĻŸāĻž āĻļā§āĻŦā§‡āĻ¯āĻŧāĻžā§° āĻ•ā§°āĻž āĻ¨āĻžāĻ‡
āĻŦāĻŋāĻ•āĻžāĻļāĻ•ā§°ā§āĻ¤āĻžāĻ‡ āĻĄā§‡āĻŸāĻž āĻļā§āĻŦā§‡ā§ŸāĻžā§° āĻ•ā§°āĻžā§° āĻŦāĻŋāĻˇā§Ÿā§‡ āĻ•ā§‡āĻ¨ā§‡āĻ•ā§ˆ āĻ˜ā§‹āĻˇāĻŖāĻž āĻ•ā§°ā§‡ āĻ¸ā§‡āĻ‡ āĻŦāĻŋāĻˇā§Ÿā§‡ āĻ…āĻ§āĻŋāĻ• āĻœāĻžāĻ¨āĻ•
āĻāĻ‡ āĻāĻĒā§â€ŒāĻŸā§‹ā§ąā§‡ āĻāĻ‡ āĻ§ā§°āĻŖā§° āĻĄā§‡āĻŸāĻž āĻ¸āĻ‚āĻ—ā§ā§°āĻš āĻ•ā§°āĻŋāĻŦ āĻĒāĻžā§°ā§‡
āĻāĻĒā§° āĻ•āĻžā§°ā§āĻ¯āĻ•āĻ˛āĻžāĻĒ āĻ†ā§°ā§ āĻĄāĻŋāĻ­āĻžāĻ‡āĻš āĻ…āĻĨāĻŦāĻž āĻ…āĻ¨ā§āĻ¯ āĻ†āĻ‡āĻĄāĻŋ
āĻĄā§‡āĻŸāĻž āĻŸā§ā§°ā§‡āĻ¨āĻœāĻŋāĻŸāĻ¤ āĻāĻ¨āĻ•ā§ā§°āĻŋāĻĒā§āĻŸ āĻ•ā§°āĻž āĻšā§Ÿ
āĻĄā§‡āĻŸāĻž āĻŽāĻšāĻŋāĻŦ āĻ¨ā§‹ā§ąāĻžā§°āĻŋ

āĻ¨āĻ¤ā§āĻ¨ āĻ•āĻŋ āĻ†āĻ›ā§‡

â€ĸ New 2024 CDC Contraceptive Guidelines
â€ĸ You can now save specific recommendations for easy access